ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological Examinations

@article{Sundin2008ENETSCG,
  title={ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological Examinations},
  author={Anders Sundin and Marie-Pierre Vullierme and Gregory A. Kaltsas and U. Pl{\"o}ckinger},
  journal={Neuroendocrinology},
  year={2008},
  volume={90},
  pages={167 - 183}
}
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors : Radiological Examinations 
ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors
ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System : Well-Differentiated Pancreatic Non-Functioning Tumors
Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Neuroendocrine gastro-entero-pancreatic tumors : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Tumor Staging: Pancreas
In patients with pancreatic neuroendocrine tumors (pNETs), the assessment of the tumor extent and location and the evaluation of any possible local and/or distant metastases are both required to
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
Guidelines for the management of neuroendocrine tumours by the Brazilian gastrointestinal tumour group
TLDR
Brazilian guidelines considered the best feasible strategies in an environment involving more limited resources to recommend their best management of neuroendocrine tumours.
Resection Versus Chemotherapy for Metastatic Neuroendocrine Tumors of the Pancreas
TLDR
This chapter focuses on the debate between surgery and chemotherapy for metastatic PNET, and summarizes the evidence for both strategies including which treatment is appropriate in each clinical setting.
NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.
TLDR
An overview of well-differentiated neuroendocrine tumors of the stomach and pancreas is provided and consensus guidelines for the treatment of patients with these malignancies are described.
The overriding role of surgery and tumor grade for long‐term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population‐based cohort study
Gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) comprise a heterogeneous disease group. Factors that affect long‐term survival remain uncertain. Complete population‐representative cohorts
Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours
TLDR
These Nordic guidelines, written by a group with a major interest in the subject, summarises the current view on how to diagnose and treat patients with neuroendocrine tumours.
Anatomic and Functional Imaging of Neuroendocrine Tumors
TLDR
Accurate and effective imaging is paramount to the diagnosis, staging, therapy, and surveillance of patients with NET.
...
...

References

SHOWING 1-10 OF 54 REFERENCES
MRI of pancreatic neuroendocrine tumours.
TLDR
The spectrum of MRI appearances of pancreatic neuroendocrine tumours is reviewed to suggest that MRI may have an important role in their localization.
Nonfunctioning endocrine tumors of the pancreas: possibilities of spiral CT characterization
TLDR
This study assesses the ability of spiral CT to adequately characterize the nonfunctioning endocrine tumors of the pancreas, distinguishing this lesion from the other pancreatic tumors, and finds that the diagnosis of NFET is allowed but without certainty.
Neuroendocrine tumors of the pancreas: Spectrum of appearances on MRI
TLDR
Most neuroendocrine tumors of the pancreas are low signalintensity on fat‐suppressed T1‐weighted images and moderately high in signal intensity onFat‐Suppressed T2‐ Weighted images, although variations do exist.
Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management.
TLDR
Because of the ability of SRS to alter clinical management combined with its superior sensitivity, high specificity, simplicity, and cost-effectiveness, SRS should be the initial imaging modality for patients with gastrinomas.
Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas
TLDR
The results support the use of EUS as a primary diagnostic modality in the evaluation and management of patients with neuroendocrine tumors of the pancreas and show EUS was more accurate than angiography with or without stimulation testing, transcutaneous ultrasound, and CT in those patients undergoing further imaging procedures.
CT of pancreatic islet cell tumors.
In 41 patients with clinical evidence of pancreatic islet cell tumors, CT detected 21 of 27 tumors that were proved at surgery (sensitivity 78%) and correctly excluded the diagnosis in 14 of 14
Endosonography in decision making and management of gastrointestinal endocrine tumors.
Endoscopic Ultrasonography of Neuroendocrine Tumours
TLDR
Endoscopic ultrasonography (EUS) offers ideal conditions to localize and stage NETs of the foregut and provides the best information on local tumor invasion and regional lymph node involvement in nonfunctional NETs.
...
...